LEADER 03679nam  22007095  450 
001 9910300201203321
005 20250714143230.0
010   $a3-319-06062-7
024 7 $a10.1007/978-3-319-06062-0
035   $a(CKB)3710000000251256
035   $a(EBL)1965098
035   $a(OCoLC)908083167
035   $a(SSID)ssj0001372719
035   $a(PQKBManifestationID)11767976
035   $a(PQKBTitleCode)TC0001372719
035   $a(PQKBWorkID)11305153
035   $a(PQKB)10126471
035   $a(DE-He213)978-3-319-06062-0
035   $a(MiAaPQ)EBC1965098
035   $a(PPN)182092313
035   $a(EXLCZ)993710000000251256
100   $a20141001d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aNew Therapeutic Strategies in Lung Cancers /$fedited by Solange Peters, Benjamin Besse
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (255 p.)
300   $aDescription based upon print version of record.
311 08$a3-319-06061-9 
320   $aIncludes bibliographical references.
327   $aPreface -- Foreword -- Screening -- New Diagnostic Approaches -- PET and Staging Minimally Invasive (EBUS) -- Innovative Approaches in Early NSCLC -- Minimally Invasive Surgery for Early NSCLC -- Stereotaxic Radiotherapy in Localized Cancer -- How to Personalize Perioperative Chemotherapy in Early Cancer ? -- New Approaches in Locally Advanced NSCLC -- Advances in Radiotherapy for Locally Advanced NSCLC -- Advances in Systemic Treatment for Locally Advanced NSCLC -- Surgery of Advanced Tumors -- New Approaches in Stage IV NSCLC -- How to Personalize Chemotherapy in Stage IV NSCLC? -- Supportive Care -- Molecular Subgroups -- Strategies in EGFR Mutated NSCLC Patients -- Strategies in ALK Rearranged NSCLC patients -- Strategies in KRAS mutated NSCLC Patients -- Strategies in Patients with Other Molecular Alterations -- New Approaches in Immunotherapy -- Management of Particular Cases -- Oligometastasis -- Bone Metastasis -- Brain Metastasis.
330   $aThis book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods, including new radiotherapy techniques and anticancer strategies like immunotherapy. New strategies for patients with molecular alterations and the management of particular types of cases are also highlighted. Written by recognized experts in their field, the book represents a unique and valuable resource in the field of lung cancer, both for those currently in training and for those already in clinical or research practice.
606   $aOncology
606   $aCancer$xTreatment
606   $aSurgery
606   $aRadiology
606   $aOncology
606   $aCancer Therapy
606   $aSurgery
606   $aRadiology
615  0$aOncology.
615  0$aCancer$xTreatment.
615  0$aSurgery.
615  0$aRadiology.
615 14$aOncology.
615 24$aCancer Therapy.
615 24$aSurgery.
615 24$aRadiology.
676   $a610
676   $a615842
676   $a616994
676   $a617.54059
702   $aPeters$b Solange$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBesse$b Benjamin$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300201203321
996   $aNew Therapeutic Strategies in Lung Cancers$91866843
997   $aUNINA